A review of the Pennsylvania Medical Marijuana Program defined the symptom profile of patients with breast cancer who sought to use medical marijuana.
To compare the oncologic outcomes of patients with non-metastatic muscle-invasive bladder cancer (MIBC) undergoing complete versus incomplete transurethral tumor resection (TURBT) prior to radiation therapy.
The OncoAlert Newsletter is now out for June 23-29, 2023
The Second International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
Format focusing on your clinical practice – Get a full update on prostate cancer, in a multidisciplinary and international setting.
This cohort study examines whether prediagnostic use of 5-alpha-reductase-inhibitors is associated with mortality outcomes among individuals with prostate cancer.
This cohort study examines whether prediagnostic use of 5-alpha-reductase-inhibitors is associated with mortality outcomes among individuals with prostate cancer.
This cohort study examines whether prediagnostic use of 5-alpha-reductase-inhibitors is associated with mortality outcomes among individuals with prostate cancer.
The Second International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
The Second International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
Return to work 2 years after a breast cancer diagnosis is associated with higher cognitive speed performance before and after treatment.
